Clinical Trial Update: Safety and Immunogenicity Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating safety and immunogenicity of the ACYW135 meningococcal polysaccharide vaccine in people aged 2-50; the trial status is currently UNKN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• ACYW135 Meningococcal Polysaccharide Vaccine (ACYW135 meningococcal polysaccharide vaccine)

Snippet

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention | Conditions: ACYW135 Meningococcal Polysaccharide Vaccine | Phase 3 | Status: UNKNOWN